By way of derogation from point (b) of Article 8(1), an applicant for a marketing authorisation for a veterinary medicinal product shall not be required to provide the technical documentation on quality, safety and efficacy if that applicant demonstrates permission, in the form of a letter of access, to use such documentation submitted in respect of the already authorised veterinary medicinal product.
Home› Food & Health Safety› Veterinary Medicinal Products Regulation
Chapter II · MARKETING AUTHORISATIONS – GENERAL PROVISIONS AND RULES ON APPLICATIONS › Section 5 · Specific requirements for generic, hybrid and combination veterinary medicinal products and for applications based on informed consent and bibliographic data › Article 21
Application based on informed consent
←→ also move between articles